Literature DB >> 25537343

Measuring tissue back-pressure--in vivo injection forces during subcutaneous injection.

Andrea Allmendinger1, Robert Mueller, Edward Schwarb, Mark Chipperfield, Joerg Huwyler, Hanns-Christian Mahler, Stefan Fischer.   

Abstract

PURPOSE: Limited information is available on injection forces of parenterals representing the in vivo situation. Scope of the present study was to investigate the contribution of the subcutaneous (sc) tissue layer to injection forces during in vivo injection.
METHODS: Göttingen minipigs received injections of isotonic dextran solutions (1-100 mPas) into the plica inguinalis using different injection rates and volumes (0.025-0.2 mL/s and 2.5 vs. 4.5 mL).
RESULTS: The contribution of the sc back-pressure to injection forces was found to increase linearly with viscosity and injection rate ranging from 0.6 ± 0.5 N to 1.0 ± 0.4 N (1 mPas), 0.7 ± 0.2 N to 2.4 ± 1.9 N (10 mPas), and 1.8 ± 0.6 N to 4.7 ± 3.3 N (20 mPas) for injection rates of 0.025 to 0.2 mL/s, respectively. Variability increased with viscosity and injection rate. Values are average values from 10 randomized injections. A maximum of 12.9 N was reached for 20 mPas at 0.2 mL/s; 6.9 ± 0.3 N was determined for 100 mPas at 0.025 mL/s. No difference was found between injection volumes of 2.5 and 4.5 mL. The contribution of the tissue was differentiated from the contribution of the injection device and a local temperature effect. This effect was leading to warming of the (equilibrated) sample in the needle, therefore smaller injection forces than expected compensating tissue resistance to some parts.
CONCLUSIONS: When estimating injection forces representative for the in vivo situation, the contribution of the tissue has to be considered as well as local warming of the sample in the needle during injection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25537343     DOI: 10.1007/s11095-014-1611-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  33 in total

1.  Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions.

Authors:  V Burckbuchler; G Mekhloufi; A Paillard Giteau; J L Grossiord; S Huille; F Agnely
Journal:  Eur J Pharm Biopharm       Date:  2010-08-16       Impact factor: 5.571

2.  A recombinant human enzyme for enhanced interstitial transport of therapeutics.

Authors:  L H Bookbinder; A Hofer; M F Haller; M L Zepeda; G-A Keller; J E Lim; T S Edgington; H M Shepard; J S Patton; G I Frost
Journal:  J Control Release       Date:  2006-06-07       Impact factor: 9.776

3.  Injectability of biodegradable in situ forming microparticle systems (ISM).

Authors:  W Rungseevijitprapa; R Bodmeier
Journal:  Eur J Pharm Sci       Date:  2008-12-14       Impact factor: 4.384

Review 4.  The utility of the minipig as an animal model in regulatory toxicology.

Authors:  Gerd Bode; Peter Clausing; Frederic Gervais; Jeanet Loegsted; Jörg Luft; Vicente Nogues; Jennifer Sims
Journal:  J Pharmacol Toxicol Methods       Date:  2010-05-31       Impact factor: 1.950

5.  The panniculus carnosus in the domestic pig.

Authors:  E H Rose; L M Vistnes; G A Ksander
Journal:  Plast Reconstr Surg       Date:  1977-01       Impact factor: 4.730

6.  The effect of a new syringe design on the ability of rheumatoid arthritis patients to inject a biological medication.

Authors:  Ali Sheikhzadeh; Jangwhon Yoon; Dan Formosa; Barbara Domanska; Darrell Morgan; Michael Schiff
Journal:  Appl Ergon       Date:  2011-06-21       Impact factor: 3.661

7.  Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers.

Authors:  Cecile Berteau; Florence Schwarzenbach; Yves Donazzolo; Mathilde Latreille; Julie Berube; Herve Abry; Joël Cotten; Celine Feger; Philippe E Laurent
Journal:  Patient Prefer Adherence       Date:  2010-10-05       Impact factor: 2.711

Review 8.  Development of a subcutaneous formulation for trastuzumab - nonclinical and clinical bridging approach to the approved intravenous dosing regimen.

Authors:  B Bittner; W F Richter; F Hourcade-Potelleret; C McIntyre; F Herting; M L Zepeda; J Schmidt
Journal:  Arzneimittelforschung       Date:  2012-08-23

9.  Influence of human skin specimens consisting of different skin layers on the result of in vitro permeation experiments.

Authors:  A Henning; D Neumann; K-H Kostka; C-M Lehr; U F Schaefer
Journal:  Skin Pharmacol Physiol       Date:  2008-01-11       Impact factor: 3.479

10.  Variability in syringe components and its impact on functionality of delivery systems.

Authors:  Nitin Rathore; Pratik Pranay; Bruce Eu; Wenchang Ji; Ed Walls
Journal:  PDA J Pharm Sci Technol       Date:  2011 Sep-Oct
View more
  12 in total

1.  Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products.

Authors:  Andrea Allmendinger
Journal:  Pharm Res       Date:  2021-04-26       Impact factor: 4.200

2.  Assessment of Forces in Intradermal Injection Devices: Hydrodynamic Versus Human Factors.

Authors:  Stijn Verwulgen; Koen Beyers; Timothi Van Mulder; Thomas Peeters; Steven Truijen; Francis Dams; Vanessa Vankerckhoven
Journal:  Pharm Res       Date:  2018-04-18       Impact factor: 4.200

3.  Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release.

Authors:  Veronika Schmitt; Claudia Kesch; John K Jackson; Samir Bidnur; Eliana Beraldi; Virginia Yago; Mary Bowden; Martin E Gleave
Journal:  Pharm Res       Date:  2020-01-21       Impact factor: 4.200

Review 4.  Translational Applications of Hydrogels.

Authors:  Santiago Correa; Abigail K Grosskopf; Hector Lopez Hernandez; Doreen Chan; Anthony C Yu; Lyndsay M Stapleton; Eric A Appel
Journal:  Chem Rev       Date:  2021-05-03       Impact factor: 60.622

5.  Effect of two methods and two anaesthetics for local anaesthesia of piglets during castration.

Authors:  Lotte Skade; Charlotte Sonne Kristensen; Mai Britt Friis Nielsen; Line Hummelmose Diness
Journal:  Acta Vet Scand       Date:  2021-01-06       Impact factor: 1.695

6.  Novel cannula design improves large volume auto-injection rates for high viscosity solutions.

Authors:  Bruce C Roberts; Christopher Rini; Rick Klug; Douglas B Sherman; Didier Morel; Ronald J Pettis
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

7.  The effects of gravity and compression on interstitial fluid transport in the lower limb.

Authors:  James W Baish; Timothy P Padera; Lance L Munn
Journal:  Sci Rep       Date:  2022-03-22       Impact factor: 4.996

8.  Formative Study on the Wearability and Usability of a Large-Volume Patch Injector.

Authors:  Jakob Lange; Andreas Schneider; Christoph Jordi; Michael Lau; Timothy Disher
Journal:  Med Devices (Auckl)       Date:  2021-11-16

9.  Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects.

Authors:  Wendy D Woodley; Wen Yue; Didier R Morel; Audrey Lainesse; Ronald J Pettis; Natasha G Bolick
Journal:  Clin Transl Sci       Date:  2021-03-25       Impact factor: 4.689

10.  Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults.

Authors:  Wendy D Woodley; Didier R Morel; Diane E Sutter; Ronald J Pettis; Natasha G Bolick
Journal:  Clin Transl Sci       Date:  2021-11-10       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.